ACR Releases 2024 Guideline Summary for Lupus Nephritis
2024年11月25日 · Recommended treatment includes pulse intravenous glucocorticoids (250-1000 mg/day for 1-3 days) transitioning to oral dosing (≤0.5 mg/kg/day), with the goal of tapering to a dose of 5 mg/day or less by 6 months.
2022 ACR/AAHKS Guidelines for Management of
2022年4月6日 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip …
Facet Hypertrophy | Diagnosis & Disease Information
2022年9月12日 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or falls. 1
Tirzepatide Bests Semaglutide in Head-to-Head Weight Loss Trial
2024年12月11日 · The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects. Tirzepatide provided superior weight loss when compared with semaglutide in the SURMOUNT-5 trial.
FDA Roundup: Rheumatology Drug Alerts 2024
2024年3月5日 · Throughout 2024, the United States Food and Drug Administration (FDA) approved new drugs for the treatment of osteoporosis, rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), giant cell arteritis, Duchenne muscular dystrophy (DMD), and certain cancers, while also expanding treatment indications for previously approved drugs.
American College of Rheumatology Releases Updated Guidelines …
2021年6月18日 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
PATIENT FACT SHEET Copyright © 2024 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form ...
Rheumatology ICD 10 Codes
2023年5月10日 · This is a comprehensive table of rheumatology ICD 10 codes used by researchers as well as healthcare professionals and personnel—nurses, medical coders, physicians, et al.
Calcium Pyrophosphate Deposition Disease (CPPD)
2022年10月5日 · History and Epidemiology. Calcium pyrophosphate deposition disease (CPPD) is a crystal deposition arthropathy that involves the synovial and periarticular tissues, 1 often characterized by painful swelling in one or more joints. 2 Other names that have been traditionally used for CPPD are chondrocalcinosis, pyrophosphate arthropathy, and most especially, pseudogout. 3 It is commonly known as ...
Metformin Shows Promise for Reducing Symptoms of Sjögren …
2024年11月21日 · Metformin may improve salivary gland function and reduce ocular symptoms among patients with Sjögren syndrome, according to study results presented at the American College of Rheumatology (ACR) Convergence 2024, held from November 14 to 19, in Washington, DC.. Sjögren syndrome is a systemic autoimmune disorder marked by lymphocytic infiltration of the exocrine glands, leading to symptoms ...